Jagsonpal Pharmaceuticals
JAGSNPHARM · Pharma > Pharmaceuticals & Drugs · Chairman: R P S Kochhar · MD: R P S Kochhar · Listing date: Sept. 12, 1996 · New Delhi · http://www.jagsonpal.com

Stock Price vs Company Growth
1d
11.5%
1w
28.2%
1m
37.4%
3m
53.3%
6m
84.3%
1y
51.7%
5y
87.3%
10y
37.6%
all
23.4%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 599 11.5%
346
607
Company Overview

Sales
227 Cr
Growth: -6.3%
Profit after Tax
24.3 Cr
Growth: 19.6%
Small Cap
1,588 Cr
P/E: 66.9x
Industry P/E: 41.6x
Fundamentals

Sales (Cr) ₹ 227
Growth -6.3%
EBITDA 14.4%
P/S 7.0x
Dividend 1.1%
P/E 66.9x
Book Value ₹ 77.1
PEG Ratio -10.6x
ROE 12.8%
P/B 7.8x
Shareholding Pattern

Institutions
Promoters
Aresko Progressive Private Limited
65.71 %
Rajpal Singh Kochhar
4.63 %
Others
Investor Education And Protection Fund Authority
1.56 %
Sanjiv Kumar Dudeja
1.41 %
Lincoln P Coelho
1.16 %
Increase    Decrease    No change
Company Profile Detailed

In 1964 Jagsonpal started from humble beginnings with Jagmohan S. Kochhar operating a chemists shop in Delhi. Soon he expanded into making formulations. Mr. Kochhar’s vision was to spread health and healing in India on a larger scale. He was at the helm of the company from its inception, through the startup phase. Even though Jagsonpal was a small business at the time, his vision was to create one of India’s premiere pharmaceutical companies.
Investors (22)